{"name":"Intersect ENT","slug":"intersect-ent","ticker":"","exchange":"","domain":"","description":"Intersect ENT, a subsidiary of Medtronic, is a health care equipment company based in Menlo Park, California. It manufactures drug-delivery devices used by Ear, Nose & Throat (ENT) clinicians in the treatment of sinusitis. Intersect ENT is best known for developing the first bioabsorbable drug-eluting sinus stent PROPEL, which delivers anti-inflammatory medication directly to the sinuses. The company holds over 20 issued patents in the United States and more than 80 patents and patent applications worldwide. The company was named on the Forbes list of America's Most Promising Companies and was also on the Fierce 15 list of Most Promising Companies in 2013.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":106748000,"revenueGrowth":32.5,"grossMargin":0,"rdSpend":27944000,"netIncome":-159635000,"cash":146867000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2021"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"S8 Sinus Implant","genericName":"S8 Sinus Implant","slug":"s8-sinus-implant","indication":"Treatment of chronic sinusitis","status":"phase_3"}]}],"pipeline":[{"name":"S8 Sinus Implant","genericName":"S8 Sinus Implant","slug":"s8-sinus-implant","phase":"phase_3","mechanism":"S8 Sinus Implant is a drug that delivers corticosteroids directly to the nasal passages to reduce inflammation and swelling.","indications":["Treatment of chronic sinusitis","Treatment of nasal polyps"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9vLWJkaTZmWGZTM1k5NGEzOUlFbkNkZ29YcjN0UjBRT0xiTHYzS2owYjdWVlgybWFJYWgxZklUYnh1d1RIX3QxaWtrZDJQXzNzNWFmWGROSWh1QXhMenhqX1VaMlBwbHdfQ1JvUjNTcEhvMUlQTXB5UQ?oc=5","date":"2026-02-25","type":"pipeline","source":"Research Nester","summary":"Mometasone Furoate Market Size & Share, Growth Trends 2035 - Research Nester","headline":"Mometasone Furoate Market Size & Share, Growth Trends 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOZTB6c3ZPanRfRlNNNHFmOUwxeEtJUUhrZzBWUDYtTG1wczlsQzdKWFBtd283Tm5Ib3BfUDk4RlpoSmRIMlZ6Q0VrZVBkSjRKamliVWNIZllUS1JhcTZaT1FDQm9WNjNwdnlJY25vTURyaDJyTmlRTzJFMGp2Q0ZFV0k3VHQ?oc=5","date":"2022-05-16","type":"deal","source":"Medical Product Outsourcing","summary":"Medtronic Closes $1.1B Intersect ENT Deal - Medical Product Outsourcing","headline":"Medtronic Closes $1.1B Intersect ENT Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxObDJFOEsyYWYxNG9naW8zTm9HLU5yelFTMXZiTC1BU215bkl5WXV5dEJKUWJJWVhjYWtPXzM0TV91aFlaLS04N0dwNmFWYWpWNkZaTnZrbHlOZTIxSk5hRzJtQUxkQ1dWSTlSNVlsZFNxZkUxVmtseVFtZGg3X1R0X2ZKR0RCd05mbW9pWWpJZUNNT2RkcWwtZVhqUUZMRnVZMXdYdFlLLXZjUHF5SGFNeVNjem91X25aMlZFb3dkZktLd2tsS00yV2V4NE14ZHFaWXBxWS1B?oc=5","date":"2022-05-15","type":"pipeline","source":"respiratory-therapy.com","summary":"Medtronic Completes Acquisition of Intersect ENT - respiratory-therapy.com","headline":"Medtronic Completes Acquisition of Intersect ENT - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQb05ldS1rLXZaR25malR0V0ZGeFhETHhfZjA0YU1TdmtGSnZOVHZLRWhyMW5DSVNDeXFvU3ljQ1hScEI1UVQtbm1QM28wY1hhb0dMSG9Yb0ptLTZnZFJuSG45NkprS3lMZlJWYTRIMGdJWEFZRjZDR1JiVERvMjRxZGZYUTF4UVNvWU9oSVB0bWFFWkxFcjFraUpDQzdjV2ZfUWFKUVIwQQ?oc=5","date":"2022-05-13","type":"pipeline","source":"PR Newswire","summary":"Medtronic completes acquisition of Intersect ENT - PR Newswire","headline":"Medtronic completes acquisition of Intersect ENT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQQzVQVVhpRkVSblBYa2xJT0ZpajFIMXFhYUZKSXVNTzkyWWpDbDUwNmFoRG9HXzhDNnJ3V012STl0REJXRUJ5LV9POENFQ2wwNmthVFVVdmxLVFhiazFmdVp3MmJMX2ZMeG1CQ3RSdnJVZExVVWM0VGwxc2dhQ0xmcFlFZC0zN21Femp3?oc=5","date":"2022-05-13","type":"pipeline","source":"Drug Delivery Business","summary":"Medtronic completes Intersect ENT acquisition - Drug Delivery Business","headline":"Medtronic completes Intersect ENT acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPU1VMOXRnTW42UXIwaDZTalA0VWtkN1VvWEpQcE1PaTVGM29BUlpMUXIxeHFyRGNjZzhQRTZaOXY3MVdsZVhvMXFxT1VnM215VVVkNVNGTlJ2TU5NZ3N3OGNJaXdoVmpjcDRUZGl1b2NZYkxISVRNNU02RXJLZFhoSS1jS2RoT1BXd2FfV09MMFQ4ekNZQWlUeVgtcHg2c21EMGlLeVlsZ19YMmlzT0hJMDNNM1dCaFQtTGpsdg?oc=5","date":"2022-05-13","type":"regulatory","source":"Fierce Biotech","summary":"Medtronic makes FTC-mandated sale to close Intersect ENT deal and scores FDA nod to boot - Fierce Biotech","headline":"Medtronic makes FTC-mandated sale to close Intersect ENT deal and scores FDA nod to boot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOOW1WbVBiMzJzelJ4b1BGVnU2WjhCNVRXZVlFNDBEN21KNVpob29iZi1GdzZUTE9GbDVncmNKNmNDdEZCV2dhZW1zNFFoQkNjbWZ6RUJFOGp4MmpNQ054UTIwQ0FHOGpWelkwdEtaa2NkbnhqZ1RNMjNLYmRMb1ZMZzJHTE9QU2tmSG9PWVV0cERSbDJl?oc=5","date":"2021-08-06","type":"deal","source":"PR Newswire","summary":"Medtronic to Acquire Intersect ENT - PR Newswire","headline":"Medtronic to Acquire Intersect ENT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxON2k3QWlPa19Lb2oycnVULXo3SDYzY3RJNWd3NkE3Q2dQVFhhUk5VR3I4RHlLeEpYeGJvU2RpUl84TmdZU3NEOEpUNnFnSXBEUVRxWlctZGFfZVlubkRLcVFMRkNGRTNLY3ktQ2ZTVmw3TFcyX3J4NGE5UFlmYjJFMzM0WWhfWks3eXI1d3MxdlJjY3JWMkN3ZHhSSk1JWS1xd0JVTDZMelJHQUNaSWM2T0p2ZU44S1dRdEc0ZDFZNGtyZjZqRnc?oc=5","date":"2021-08-06","type":"pipeline","source":"Fierce Biotech","summary":"Medtronic boosts ear, nose and throat portfolio with $1.1B bid for sinus implant maker Intersect ENT - Fierce Biotech","headline":"Medtronic boosts ear, nose and throat portfolio with $1.1B bid for sinus implant maker Intersect ENT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNTm0wOXhwcFl4ZVUtaGwyWV8ydXNjakd5SWpXRXlZTkNqRzNJWnJxQkM0NWs2Y0RQb1RydjNQZEFQMnRkZXZGSGNtU1pCeEhBQjUzdWlSRjRLYnBZOWlMMURndEJsMFV2d1VtN21sS2FpSWp6RW96SnN4bDRfc3M0Ny1kVnlmaGlIMmFGUnlPVmJzQWRmUmhsbU9vN1Z4Zw?oc=5","date":"2020-09-16","type":"deal","source":"Medical Device Network","summary":"Intersect ENT to acquire Fiagon AG Medical Technologies - Medical Device Network","headline":"Intersect ENT to acquire Fiagon AG Medical Technologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxOT2pIM2QyaEpoNFFCMGpNODd5UUJjR2dBcjJRTEEzclUwcjRmRXRTQUpyaVBlZUk2a1cwY0lJRk9IR00wQW9pLXRSLVo4SWNKbWVnOE4ybmVaRXRHNm5QOFdQSTNfS1Y5ekFVYXp0eFRsd21nb3dudGxfazZGbWVLZVBQNGF4VUdBWnlCQmJZMXFwRjg3YkI0NDJyS241M3NueWtVQ2VtSTBYY095Q1BzVlh5M1BhZHNHTEMwNFptZF9kbkh5aFBHUUFzenBDRGlyNE91WldGLTBQQnpuYzdOZWVSMWxzVDBJ?oc=5","date":"2017-03-01","type":"regulatory","source":"Medical Design & Outsourcing","summary":"Intersect ENT Announces FDA Approval Of PROPEL Contour, For Use In Treating The Frontal And Maxillary Sinuses - Medical Design & Outsourcing","headline":"Intersect ENT Announces FDA Approval Of PROPEL Contour, For Use In Treating The Frontal And Maxillary Sinuses - Medical ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPT0dicnNCS18zXzQ3cXNpeTFvLWprYnVTeXFzaTRlelUzc1RHZVhVbjlkWS05WVNQVm56cm1yWFJHZnpydS1VdFFDZFJXVktTWTJ6WkhrQnhVRTFDMHhfLXZuSGthb2NONWRsZzJBc3ZaX3l3Z2o4WnR3WU9aYWVXOGhoakN1aWNreUkzM3IwOVY1b0VJa1Y3UW84d1BLUlcyVl9ncm9YWHI?oc=5","date":"2017-02-24","type":"regulatory","source":"Drug Delivery Business","summary":"Intersect ENT wins FDA nod for Propel Contour steroid-releasing implant - Drug Delivery Business","headline":"Intersect ENT wins FDA nod for Propel Contour steroid-releasing implant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQSHNKandCM0pHWTk5Y1hFR3E1bHdIUUZ1OUV1TU9nSmMzUTFCcTRQT21zX3Q0c0xSM2JQTWFNaUZONERXcnB5TlZFd1ZDYmhFaGVVZmZOMnhvSEMwdVJiaEZDWHExbXJsX2VyZGFtb205ZE9Jek56a3VLLUNQeWxRUWx1TFpWYlNoTm0yTGMtelJnYmF1M3RGLWxhLWJKSUJJSHVLUnJMelFtN0RZX1ZVdUNGNmk2aFZEb0xYVlNBTHRPYkI4Q2l4QU9RdHVrQW9yeTN3?oc=5","date":"2014-07-29","type":"pipeline","source":"GlobeNewswire","summary":"Intersect ENT Announces Closing of its Initial Public Offering - GlobeNewswire","headline":"Intersect ENT Announces Closing of its Initial Public Offering","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":106748000,"revenuePeriod":"2021-12-31","revenueHistory":[{"value":106748000,"period":"2021-12-31"},{"value":80554000,"period":"2020-12-31"},{"value":80554000,"period":"2020-12-31"},{"value":109142000,"period":"2019-12-31"},{"value":109142000,"period":"2019-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":27944000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-159635000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":146867000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}